U.S. Basic Materials Stock News

NYSE:DG
NYSE:DGConsumer Retailing

Dollar General (DG) Valuation Check As Digital Awards And New Private Label Brand Support Turnaround Story

Dollar General (DG) is back in focus after a flurry of customer centric moves, including multiple national awards for its digital engagement efforts and the rollout of a new private label kitchen brand, simmer & stir. See our latest analysis for Dollar General. Despite the flurry of customer awards and new product launches, recent share price momentum has been weak, with the stock down 19.18% on a 30 day share price return and 31.60% on a 90 day share price return, while the 1 year total...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

Does CEO Reuter’s Interim COO Role Reshape Management Risk At First Interstate BancSystem (FIBK)?

First Interstate BancSystem recently terminated Kristina Robbins’ role as Executive Vice President and Chief Operating Officer without cause, effective May 11, 2026, and reassigned her to a temporary Executive Advisor position supporting CEO James Reuter while he assumes interim COO responsibilities. This reshaping of the senior leadership team concentrates operational control with the CEO during the search for a new COO, raising questions about how execution and oversight will be managed in...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

A Look At Agilysys (AGYS) Valuation As AI-Powered Hospitality Solutions Gain Customer Traction

Agilysys (AGYS) stock is back in focus after the company used its INSPIRE 2026 conference to showcase more than 30 AI-powered features that customers report are improving efficiency, guest engagement, and revenue performance. See our latest analysis for Agilysys. Despite the recent INSPIRE 2026 product announcements and upcoming earnings update, Agilysys' share price has fallen 41.7% year to date and the 1 year total shareholder return is down 18.9%. However, the 5 year total shareholder...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

A Look At Nurix Therapeutics (NRIX) Valuation After New NX-5948 Data And EHA Congress Selection

Nurix Therapeutics (NRIX) is back in focus after reporting new preclinical and Phase 1 data for its BTK degrader NX-5948, and after securing an oral presentation slot at the European Hematology Association Congress. See our latest analysis for Nurix Therapeutics. Despite the recent NX-5948 data and the upcoming European Hematology Association presentation, Nurix Therapeutics’ share price has eased over the past month, with a 30 day share price return of 9.45% down, even as the 1 year total...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

How Investors Are Reacting To Golar LNG (GLNG) Mounting Cash Burn And Dilution Risks

In recent commentary, investors have focused on Golar LNG’s multi-year 2.7% annual sales decline and continued cash burn, which raise questions about its financial resilience. An important concern is the possibility that these pressures could eventually require new fundraising, potentially diluting existing shareholders and challenging confidence in the company’s long-term plan. Next, we’ll examine how these worries about cash burn and potential fundraising intersect with Golar LNG’s...
NYSE:EQR
NYSE:EQRResidential REITs

Is It Time To Reassess Equity Residential (EQR) After Recent Share Price Swings?

If you are wondering whether Equity Residential at around US$63.88 is offering value or just treading water, the stock’s recent performance gives you a useful starting point. The share price is up 3.0% year to date and 1.9% over the past month, although it is down 3.5% over the last week and down 6.5% over the past year, which can change how the market is thinking about risk and opportunity. Recent coverage has focused on how Equity Residential fits into broader conversations about listed...
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

What Victory Capital Holdings (VCTR)'s Q1 2026 Earnings Beat and AUM Scale Means For Shareholders

Victory Capital Holdings, Inc. recently reported first-quarter 2026 results, with revenue of US$387.99 million and net income of US$112.14 million, and declared a quarterly dividend of US$0.50 per share payable on June 25, 2026. The firm also disclosed Total Assets Under Management of US$329.10 billion as of April 30, 2026 and a 3.8% passive stake held by Capital World Investors, underscoring both business scale and institutional investor interest. We’ll now examine how Victory Capital’s...
NYSE:CC
NYSE:CCChemicals

Chemours (CC) Is Down 8.4% After Issuing 2026 Profit Guidance Amid Q1 Net Loss

The Chemours Company recently reported first quarter 2026 results, with sales of US$1,381 million and a net loss of US$29 million, while also affirming a quarterly cash dividend of US$0.0875 per share. At the same time, Chemours issued new guidance calling for sequential net sales growth in the second quarter of 2026 and full‑year 2026 net income attributable to the company between US$165 million and US$225 million, framing a clearer profitability path after a period of losses. Now we’ll...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

Stronger Q1 Profits And New Moment Partnership Could Be A Game Changer For MarketAxess (MKTX)

In early May 2026, MarketAxess Holdings Inc. reported first-quarter 2026 results showing revenue of US$233.38 million and net income of US$77.88 million, both higher than a year earlier. Around the same time, Moment and MarketAxess announced a new interface that extends MarketAxess’s institutional fixed-income liquidity and pricing to Moment’s wealth management and advisor clients, potentially narrowing the gap between retail and institutional bond markets. We’ll now explore how...
NYSE:AMC
NYSE:AMCEntertainment

A Look At AMC Entertainment (AMC) Valuation After Analyst Upgrade And Arena One Concert Launch

AMC Entertainment Holdings (AMC) is back in focus after an analyst upgrade linked to improving box office conditions, along with management comments on a lower revenue bar for free cash flow breakeven and the new Arena One at AMC concert format. See our latest analysis for AMC Entertainment Holdings. At a share price of $1.28, AMC has seen pressure recently, with the 7 day share price return down 9.22% and the 30 day share price return down 31.18%, while the 1 year total shareholder return is...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

Does DXPE’s Mixed Q1 2026 Earnings Hint At A Shift In Its Resilience Story?

DXP Enterprises reported past first-quarter 2026 results showing sales of US$521.66 million versus US$476.57 million a year earlier, while net income eased slightly to US$19.98 million from US$20.59 million. Management highlighted an unexpectedly weak January followed by improving trends through March, raising questions about how temporary this softness might be. Against this backdrop of early-quarter weakness and later recovery, we'll assess how the latest earnings update affects DXP...
NYSE:HL
NYSE:HLMetals and Mining

A Look At Hecla Mining (HL) Valuation After Q1 Loss And Analyst Downgrades

Hecla Mining (HL) has moved back into the spotlight after first quarter results showed a return to net loss, missing earnings expectations and triggering analyst revisions alongside a pullback in the stock. See our latest analysis for Hecla Mining. The 1-day share price return of Hecla Mining fell 9.3% after the Q1 loss and analyst revisions, contributing to a 7-day share price decline of 14.7% and a softer 90-day trend. However, the 1-year total shareholder return remains very large,...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

How Playtika’s Q1 Loss, Higher 2026 Guidance and New CFO At Playtika Holding (PLTK) Has Changed Its Investment Story

Playtika Holding Corp. recently reported first-quarter 2026 results, with sales of US$744.7 million versus US$706.0 million a year earlier, but it moved from net income of US$30.6 million to a net loss of US$57.5 million and basic and diluted loss per share of US$0.15 from earnings of US$0.08. At the same time, Playtika raised its full-year 2026 revenue outlook to a range of US$2.75 billion to US$2.85 billion, while appointing long-time internal finance leader Tae Lee, formerly of Meta...
NYSE:BEN
NYSE:BENCapital Markets

Will Franklin Resources' Tokenization and Private Markets Partnerships Redefine BEN’s Core Investment Narrative?

In May 2026, Payward, Ritholtz Wealth Management, and Franklin Templeton each announced new collaborations with Franklin Resources, ranging from onchain tokenized products and a momentum-driven equity SMA to blockchain-enabled Private Markets Model Portfolios for advisors. Together, these moves highlight Franklin Resources’ push to blend private markets, quantitative active management, and tokenization to expand how investors access and administer diversified portfolios. We’ll now examine...
NYSE:DXC
NYSE:DXCIT

A Look At DXC Technology (DXC) Valuation After Weak Results And Cautious Guidance

DXC Technology (DXC) stock is in focus after the company reported a quarterly revenue decline, missed organic growth expectations, and issued weak guidance that pointed to continued operational challenges and pressured project-based services. See our latest analysis for DXC Technology. The 8.76% 1 day share price gain to US$8.94 came after a sharp reset, with the 30 day share price return down 31.07% and the 1 year total shareholder return down 41.53%. This suggests recent earnings and...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

A Look At WD 40 (WDFC) Valuation After Earnings Beat Guidance Raise And Dividend Declaration

Event driven move in WD-40 stock WD-40 (WDFC) is back in focus after Q2 2025 results, where sales growth of 5% missed forecasts, but earnings per share beat expectations, full year profit guidance was raised, and a dividend was declared. See our latest analysis for WD-40. At a share price of US$201.37, WD-40 has given investors a modest 2.34% year to date share price return, while the 1 year total shareholder return has declined 16.76%. This suggests recent momentum has faded despite longer...
NYSE:NHI
NYSE:NHIHealth Care REITs

The Bull Case For National Health Investors (NHI) Could Change Following Q1 2026 Beat And New Guidance

National Health Investors, Inc. reported past first-quarter 2026 results with sales of US$73.15 million, total revenue of US$115.13 million, and net income of US$40.10 million, while also declaring a second-quarter dividend of US$0.92 per common share payable on August 7, 2026. Importantly, management also issued full-year 2026 net income guidance of about US$703.00 million to US$705.20 million, giving investors a clearer view of expected profitability. Next, we’ll examine how this higher...
NYSE:DKL
NYSE:DKLOil and Gas

How Delek Logistics Partners’ (DKL) 2034 Notes and Covenant Shift Has Changed Its Investment Story

Delek Logistics Partners, LP and Delek Logistics Finance Corp. recently issued US$800 million of 6.875% senior notes due 2034 and used part of the proceeds to repurchase approximately US$270.7 million of their 7.125% senior notes due 2028 via a cash tender offer, extending their debt maturity profile and adjusting interest obligations. Beyond the simple refinancing, these moves introduce new covenants that reshape Delek Logistics Partners’ financial flexibility and could influence how it...
NYSE:CCI
NYSE:CCISpecialized REITs

A Look At Crown Castle’s Valuation As Investors Reassess Its Tower Focused Reset

Why Crown Castle is Back on Investors’ Radar Crown Castle (CCI) has drawn renewed attention as investors weigh its current US$86.66 share price against its recent performance, including returns that are down over the past month and the past 3 months. See our latest analysis for Crown Castle. The recent pullback, including a 1-day share price return of 0.74% and a 7-day share price return of 4.42% lower, sits within a weaker picture. The 1-year total shareholder return is down 11.88% and the...
NasdaqGS:NWSA
NasdaqGS:NWSAMedia

A Look At News Corp (NWSA) Valuation After Latest Annual Results And Mixed Share Performance

News (NWSA) has drawn investor attention after its latest financial update, which highlighted annual revenue of US$8.8b and net income of US$447m, alongside mixed recent share performance over the past year. See our latest analysis for News. At a share price of US$25.92, News has given investors a mixed ride recently, with the 7 day share price return down 4.04% but the 3 year total shareholder return up 43.23%, suggesting that longer term holders have seen stronger momentum than short term...
NasdaqGS:EBC
NasdaqGS:EBCBanks

How D.A. Davidson’s First-Time Buy Rating Will Impact Eastern Bankshares (EBC) Investors

D.A. Davidson recently initiated coverage on Eastern Bankshares with a buy rating, marking new analyst attention on the regional bank’s prospects. While the recommendation signals fresh confidence, the analyst’s reported 0.0% one-year success rate adds an unusual context for investors assessing this new view. We’ll now examine how D.A. Davidson’s first-time buy rating might influence Eastern Bankshares’ investment narrative around its regional banking growth. Rare earth metals are the new...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

If AI Small Caps Are Next Then These Three Stocks Matter

Global markets are wrestling with stubborn inflation, higher bond yields and rising energy costs, which puts pressure on traditional playbooks and leaves many investors looking for the next engine of growth. One area drawing attention is smaller companies building real-world AI tools for machine learning, automation and data intelligence. These stocks sit away from the headlines around the mega caps and can sometimes be earlier in their growth journey, which is exactly what the AI Small Caps...
NasdaqGM:EMAT
NasdaqGM:EMATMetals and Mining

Assessing Evolution Metals & Technologies (EMAT) Valuation After Recent Trading Weakness

Evolution Metals & Technologies Stock Moves After Recent Trading Weakness Evolution Metals & Technologies (EMAT) has come onto investors’ radar after a recent stretch of softer trading, with the stock down 11% over the past day and 17% over the past week. See our latest analysis for Evolution Metals & Technologies. The recent drop fits into a wider pattern, with the share price return down over the past quarter and year to date, and the 1 year total shareholder return also in decline. This...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

Will Narrowing Losses And Per Share Improvement Reframe Rapport Therapeutics' (RAPP) Investment Narrative?

Rapport Therapeutics, Inc. reported first-quarter 2026 results, posting a net loss of US$19.86 million versus US$24.06 million a year earlier, with basic loss per share from continuing operations improving to US$0.42 from US$0.68. This narrowing loss suggests the company is tightening its cost base or managing its development spending more efficiently, which can reshape how investors assess its progress. We’ll now examine how this narrower quarterly loss and improving per-share results could...